EASTPRINT Incorporated Receives ISO 13485 Certification

NORTH ANDOVER, MA — (Marketwire) — 09/21/11 — , a designer and manufacturer of and single use sensors, , has recently received ISO 13485 certification for their quality management system. ISO 13485 is an international standard that specifies requirements for medical device manufacturers to provide a harmonized model for quality management system requirements in the international market.EASTPRINT specializes in the design and manufacture of custom which feature various types of conductive

Mattson Technology Announces Board of Directors Appointments

Mattson Technology Announces Board of Directors Appointments

FREMONT, CA — (Marketwire) — 09/20/11 — Mattson Technology, Inc. (NASDAQ: MTSN), a leading supplier of advanced process equipment used to manufacture semiconductors, today announced the appointment of Dr. Hans-Georg Betz as the chairman of the board of directors and the appointment of Scott S. Kramer as a member of the board. Dr. Betz succeeds Ken Kannappan, who will continue as a member of the board.Mr. Kannappan commented, "I am pleased to be transferring the role of chairman of the

Gate & Door Opener Market to Reach $3 Billion by 2017

Gate & Door Opener Market to Reach $3 Billion by 2017

ROCKVILLE, MD — (Marketwire) — 09/19/11 — MarketResearch.com has announced the addition of the new report "Commercial and Industrial Gate and Door Opener Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017" to their collection of market reports. For more information, visitThe commercial and industrial door and gate opener industry has seen a launch of dynamic new openers. Innovation is core to the market growth of the industry. Companies participating in the market d

Zarlink Provides Update on Shareholder Rights Plan

Zarlink Provides Update on Shareholder Rights Plan

OTTAWA, ONTARIO — (Marketwire) — 09/16/11 — Zarlink Semiconductor Inc. (TSX: ZL) ("Zarlink" or the "Company") today announced that Microsemi Corporation ("Microsemi") has made an application to the Ontario Securities Commission (the "OSC") challenging the Company-s Shareholder Rights Plan adopted by the Board on July 25, 2011. The hearing to consider Microsemi-s application has been scheduled by the OSC for October 3, 2011 and October 4, 2011.The unso

Roche-s xCELLigence System Monitors Beating Periodicity of Stem Cell Derived Cardiomyocytes in Preclinical Safety Assessment

Cardiac toxicity is a major concern in drug development and it is imperative that clinical candidates are thoroughly tested for adverse effects earlier in the drug discovery process. In a new research study (1), Abassi et al. investigated the use of Roche-s (SIX: RO, ROG; OTCQX: RHHBY) xCELLigence Cardio Instrument in conjunction with embryonic stem cell derived cardiomyocytes (ESCC) for assessment of compound risk in the drug discovery process. The xCELLigence Cardio Instrument is an impedance